Megan Arthur Schilling


I like helping companies design and implement compensation systems to drive their business by attracting, motivating and retaining top talent.

Megan Arthur Schilling focuses on compensation and benefits for public and private companies, and she counsels companies on designing, implementing and disclosing employment, incentive, change-in-control and severance arrangements. She provides strategic advice to boards of directors and management teams on these matters as well as new developments and evolving best practices in executive compensation, corporate governance and shareholder engagement. She has significant experience advising public companies on the impact of ISS, Glass Lewis and institutional investor policies and the shareholder relations issues that arise in connection with compensation and corporate governance matters.

Download full bio 


  • Metacrine – $85 Million IPO 

  • Vital Farms – $235.4 Million IPO 

  • Poseida Therapeutics – $224 Million IPO 

  • Keros Therapeutics - $110 Million IPO 

  • Zoom - $864 Million IPO 

  • View all


  • University of San Diego School of Law
    JD, magna cum laude, Order of the Coif, 2008

  • College of William & Mary
    BBA, Finance

Admissions & Credentials



  • American Bar Association

  • National Association of Stock Plan Professionals

  • San Diego County Bar Association

Rankings & Accolades

    Super Lawyers

    Rising Stars: Southern California (2015 – 2022)